Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Testing effectiveness (Phase 2)Study completedNCT00017212What this trial is testingDX-8951f in Treating Patients With Metastatic Stomach CancerWho this might be right forEsophageal CancerGastric Cancer Daiichi Sankyo
Not applicableLooking for participantsNCT05334069What this trial is testingCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more Alliance for Clinical Trials in Oncology 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT07070466What this trial is testingIvonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEAWho this might be right forStomach Cancer Stage IVEsophagus CancerStomach Cancer Massachusetts General Hospital 40
Testing effectiveness (Phase 2)WithdrawnNCT02344810What this trial is testingC-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal CancerWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Looking for participantsNCT06203600What this trial is testingAdding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE TrialWho this might be right forAdvanced Esophageal AdenocarcinomaAdvanced Gastric AdenocarcinomaAdvanced Gastroesophageal Junction Adenocarcinoma+13 more National Cancer Institute (NCI) 224
Early research (Phase 1)Study completedNCT00654160What this trial is testingIrinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerWho this might be right forAnal CancerCarcinoma of the AppendixColorectal Cancer+9 more Mayo Clinic 7
Testing effectiveness (Phase 2)UnknownNCT00003326What this trial is testingPaclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the EsophagusWho this might be right forEsophageal Cancer Theradex 100
Testing effectiveness (Phase 2)Study completedNCT00381706What this trial is testingCombination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction CancerWho this might be right forEsophageal Cancer Alliance for Clinical Trials in Oncology 245
Large-scale testing (Phase 3)Study completedNCT00978549What this trial is testingSymptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionEsophageal CancerGastric Cancer+2 more Cambridge University Hospitals NHS Foundation Trust 320
Early research (Phase 1)Not Yet RecruitingNCT07594548What this trial is testingFutibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaWho this might be right forClinical Stage II Esophageal Adenocarcinoma AJCC v8Clinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8+13 more Northwestern University 18
Testing effectiveness (Phase 2)Study completedNCT00017043What this trial is testingBMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With ChemotherapyWho this might be right forEsophageal CancerGastric Cancer Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00012363What this trial is testingS0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the EsophagusWho this might be right forEsophageal CancerGastric Cancer SWOG Cancer Research Network 61
Testing effectiveness (Phase 2)Study completedNCT00524121What this trial is testingErlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal CancerWho this might be right forEsophageal Cancer Roswell Park Cancer Institute 22
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Testing effectiveness (Phase 2)Study completedNCT00096031What this trial is testingS0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction CancerWho this might be right forEsophageal Cancer SWOG Cancer Research Network 63
Early research (Phase 1)Study completedNCT00601692What this trial is testingIrinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal CancerWho this might be right forEsophageal Cancer Memorial Sloan Kettering Cancer Center 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT04929392What this trial is testingChemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction CancerWho this might be right forClinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8+16 more City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00033657What this trial is testingRadiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal CancerWho this might be right forEsophageal CancerGastric Cancer Eastern Cooperative Oncology Group 97
Testing effectiveness (Phase 2)Study completedNCT00006081What this trial is testingCombination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach CancerWho this might be right forEsophageal CancerGastric Cancer M.D. Anderson Cancer Center 37